Journal of Urologic Oncology

Prostate Cancer

Assessing Patient Risk, Benefit, and Outcomes in Drug Development: A Decade of Abiraterone Clinical Trials: Matthew Rashid, Eli Oldham, Griffin K. Hughes, Andriana M. Peña, Chase Ladd, Brooke Gardner, Ryan McIntire, Bradley Johnson, Jordan Tuia, Alyson Haslam, Vinay Prasad, Matt Vassar; Journal of Urologic Oncology. 2024;22(3):211-223. Published online November 30, 2024; DOI: https://doi.org/10.22465/juo.244800520026
Cited By 1; Full text PubReader ePub PDF

A Machine Learning Model for Prostate Cancer Prediction in Korean Men: Sukjung Choi, Beomgi So, Shane Oh, Hongzoo Park, Sang Wook Lee, Geehyun Song, Jong Min Lee, Jung Ki Jo, Seon Hyeok Kim, Si Eun Lee, Eun-Bi Cho, Jae Hung Jung, Jeong Hyun Kim; Journal of Urologic Oncology. 2024;22(3):201-210. Published online November 30, 2024; DOI: https://doi.org/10.22465/juo.244800400020
Cited By 1; Full text PubReader ePub PDF

Simultaneous Prostate Target Biopsy Integrated With Radical Prostatectomy: A Pilot Study Omitting Preoperative Systematic Biopsy: Tae Young Park, Jae Young Hwang, Seong Woo Yun, Chang Wan Hyun, Sung Goo Yoon, Seung Bin Kim, Tae Il Noh, Ji Sung Shim, Min Goo Park, Seok Ho Kang, Sung Gu Kang; Journal of Urologic Oncology. 2024;22(3):196-200. Published online November 30, 2024; DOI: https://doi.org/10.22465/juo.244800240012
Cited By 1; Full text PubReader ePub PDF

Early Experience of the Single-Port Robotic Transvesical Radical Prostatectomy: Case Series: Jae Hoon Chung, Hwanik Kim, Woo Jin Bang, Cheol Young Oh, Jin Seon Cho; Journal of Urologic Oncology. 2024;22(3):188-195. Published online November 30, 2024; DOI: https://doi.org/10.22465/juo.244800740037
Cited By 1; Full text PubReader ePub PDF

Changes in Treatment After Gallium-68 Prostate-Specific Membrane Antigen-11 Positron Emission Tomography/Computed Tomography in Patients With Prostate Cancer: A Retrospective Case Series Study: Si Hyun Kim, Chang Wook Jeong, Minh-Tung Do, Jang Hee Han, Seung-Hwan Jeong, Hyeong Dong Yuk, Ja Hyeon Ku, Hyeon Hoe Kim, Gi Jeong Cheon, Cheol Kwak; Journal of Urologic Oncology. 2024;22(2):157-165. Published online July 31, 2024; DOI: https://doi.org/10.22465/juo.244800380019
Cited By 1; Full text PubReader ePub PDF Supplementary Material

The Integral Role and Clinical Significance of Metabolic Profiling in Prostate Cancer: A Narrative Review: Valentin Nikolaevich Pavlov, Marat Fayazovich Urmantsev, Marat Radikovich Bakeev, Olalekan Samuel Akinyemi; Journal of Urologic Oncology. 2024;22(2):150-156. Published online July 31, 2024; DOI: https://doi.org/10.22465/juo.244800260013
Cited By 1; Full text PubReader ePub PDF

Health Equity Research Outcomes and Improvement Consortium Prostate Cancer Health Precision Africa1K: Closing the Health Equity Gap Through Rural Community Inclusion: Vanessa M. Hayes, Sean M. Patrick, Joyce Shirinde, Weerachai Jaratlerdsiri, Mukudeni Nenzhelele, Mulalo B. Radzuma, Kazzem Gheybi, Winstar Mokua, Micah O. Oyaro, Daniel M. Moreira, Ikenna C. Madueke, HEROIC PCaPH AfricaK Consortium, Shingai B.A. Mutambirwa, Gail S. Prins, Mungai P. Ngugi, M.S. Riana Bornman; Journal of Urologic Oncology. 2024;22(2):144-149. Published online July 31, 2024; DOI: https://doi.org/10.22465/juo.244800340017
Cited By 1; Full text PubReader ePub PDF

Enzalutamide Maintenance Following Docetaxel in Metastatic Castration-Naive Prostate Cancer: A Pilot Feasibility Study: Sung Hee Lim, Sung Wook Cho, Jae Hoon Chung, Wan Song, Minyong Kang, Hyun Hwan Sung, Hwang Gyun Jeon, Byong Chang Jeong, Seong Il Seo, Seong Soo Jeon, Se Hoon Park; Journal of Urologic Oncology. 2024;22(1):29-33. Published online March 31, 2024; DOI: https://doi.org/10.22465/juo.244600040002
Cited By 1; Full text PubReader ePub PDF

High-Grade Late Urinary Toxicity Following Salvage Radiotherapy After Radical Prostatectomy: A Retrospective Cohort Study: Seung-Kwon Choi, Myong Kim, Sang Mi Lee, Cheryn Song, Jun Hyuk Hong, Choung-Soo Kim, Hanjong Ahn; Journal of Urologic Oncology. 2024;22(1):21-28. Published online March 31, 2024; DOI: https://doi.org/10.22465/juo.244600080004
Cited By 1; Full text PubReader ePub PDF

Multidisciplinary Team Approach in Prostate-Specific Membrane Antigen Theranostics for Prostate Cancer: A Narrative Review: Minseok Suh, Gi Jeong Cheon; Journal of Urologic Oncology. 2024;22(1):11-20. Published online March 31, 2024; DOI: https://doi.org/10.22465/juo.244600200010
Cited By 1; Full text PubReader ePub PDF

Prostate-Specific Antigen-Based Prostate Cancer Screening: One for All or Individualized for Each Race? – A Narrative Review: Chang Wook Jeong; Journal of Urologic Oncology. 2024;22(1):4-10. Published online March 31, 2024; DOI: https://doi.org/10.22465/juo.244600220011
Cited By 2; Full text PubReader ePub PDF

Clinical Predictors of ARTA Response in Metastatic Prostate Cancer

Nonregional Lymph Node Metastasis as a Predictor of Early Progression When Using Androgen Receptor Targeting Agents in Patients With Metastatic Castration-Resistant Prostate Cancer Without Previous Chemotherapy: Sihyeon Kim, Beom Yong Rho, Dong Hyuk Kang, Doo Yong Chung; Journal of Urologic Oncology. 2023;21(3):264-270. Published online November 30, 2023; DOI: https://doi.org/10.22465/juo.234600520026
Cited By 1; Full text PubReader ePub PDF

Genetic Testing and Nonsurgical Management for Renal Cell Carcinoma

Genetic Testing for Prostate Cancer, Urothelial Cancer, and Kidney Cancer: Hyunho Han, Minyong Kang, Seok-Soo Byun, Seok Joong Yun; Journal of Urologic Oncology. 2023;21(2):128-139. Published online July 31, 2023; DOI: https://doi.org/10.22465/juo.234600340017
Cited By 1; Full text PubReader ePub PDF

mpMRI in the Management of Prostate Cancer: Role, Limitation, and Cost-Effectiveness

Prostate Imaging and Reporting and Data System Version 2.1: Limitations for Clinical Use: Byung Kwan Park; Journal of Urologic Oncology. 2023;21(2):106-111. Published online July 31, 2023; DOI: https://doi.org/10.22465/juo.234600320016
Cited By 2; Full text PubReader ePub PDF

The Role of Magnetic Resonance Imaging (MRI) and MRI-Targeted Biopsy for Active Surveillance: Chang Wook Jeong; Journal of Urologic Oncology. 2023;21(2):97-105. Published online July 31, 2023; DOI: https://doi.org/10.22465/juo.234600260013
Cited By 1; Full text PubReader ePub PDF

6,014	New Drugs for Bacillus Calmette Guérin-Unresponsive Nonmuscle Invasive Bladder Cancer
5,489	The Important Role of Poly ADP-Ribose Polymerase Inhibitor in Prostate Cancer
4,997	An Update of Prostate-Specific Membrane Antigen Theranostics in Prostate Cancer
4,833	Complex Epidemiology of Prostate Cancer in Asian Countries
4,687	The Present and Future of Intravesical Therapy in Bladder Cancer

Cited By 9	Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades
Cited By 4	An Update of Prostate-Specific Membrane Antigen Theranostics in Prostate Cancer
Cited By 4	Complex Epidemiology of Prostate Cancer in Asian Countries
Cited By 3	The Evolving Role of Checkpoint Inhibitors in the Treatment of Urothelial Carcinoma: A Literature Review of Practice-Changing Trials
Cited By 2	Prostate Imaging and Reporting and Data System Version 2.1: Limitations for Clinical Use

Search